Παρασκευή 27 Οκτωβρίου 2017

Ruxolitinib partially reverses functional NK cell deficiency in patients with STAT1 gain-of-function mutations

Natural Killer (NK) cells are critical innate effector cells whose development is dependent on the JAK-STAT pathway. NK deficiency can result in severe or refractory viral infections. Patients with Signal Transducer and Activator of Transcription (STAT)1 gain of function (GOF) mutations have increased viral susceptibility.

http://ift.tt/2iFN71h

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου